Yale School of Management @YaleSOM · 13 Aug 2026
Sickle cell disease affects ~100K Americans—yet the main treatment hasn't changed since 1998. In this Q&A, Cece Calhoun '21, medical director of Yale's Sickle Cell Program, discusses leading care through burnout, bias, and the new gene therapies.👇 https://t.co/othXKl5tR7
766Views
2Likes
0Reposts
0Replies
0Quotes
0Bookmarks
Is that a lot?
1.00×vs this author's median766 views is typical
40Percentile for this authorof 5 recent posts
0.50×vs 10K–100K median1 540 views is typical
1.43%Reachviews ÷ followers
0.26%Engagement rateof viewers reacted